IBSA Choriomon 1 vial (1x 5000 IU)

HCG – human chorionic gonadotropin – Pregnyl

This non-steroidal drug is widely utilized in athletics today. HCG is a naturally occurring protein hormone produced by the human placenta, derived from the urine of pregnant women.

This hormone replicates the function of LH (Luteinizing Hormone), effectively stimulating testosterone production in men. This occurs through HCG’s action on the leydig cells in the testes, making it a viable treatment for male hypogonadism and certain ovarian disorders in women. Athletes often turn to HCG to revitalize natural testosterone production, which can decline due to long-term steroid usage. Elevated doses of steroids can mislead the hypothalamus, weakening signals to the testes and causing testicular atrophy. To combat this, athletes rely on HCG to maintain stimulation to the testes, preventing atrophy.

Upon administration, HCG significantly elevates serum testosterone levels within approximately two hours, with peak effects observed two to four days later. HCG therapy effectively prevents testicular atrophy and utilizes the body’s own stimuli to enhance plasma testosterone during training. Some steroid users report improved strength and muscle gains during HCG cycles, likely due to elevated levels of both natural and synthetic androgens. Although optimal dosing is not definitively established, many athletes find a dosage between 1000 to 2000 IU weekly yields desired outcomes. Cycles should be limited to three weeks, followed by at least a month break.

For example, athletes may employ HCG two to three weeks mid-cycle and again two to three weeks at the cycle’s conclusion. Prolonged use of HCG may interfere with the body’s natural production of gonadotropins, making short cycles preferable. Side effects can include gynecomastia, water retention, increased libido, mood swings, headaches, and hypertension. HCG can raise androgen levels by as much as 400%, but it can also elevate estrogen levels considerably, leading to risks like gynecomastia in high dosages. Nausea and vomiting may also occur.

No overdose complications have been reported with HCG, nor any links to carcinomas or organ impairment. Although there were concerns about HCG transmitting the AIDS virus, current findings indicate this is not possible. Thus, HCG remains a popular choice among athletes seeking to mitigate issues related to discontinuing steroid cycles.

This product is undetectable in steroid tests, resulting in its use by some athletes to maintain androgen levels before competitions involving drug screening. After preparation, HCG must be refrigerated and remains effective for about 10 weeks. It is administered intra-muscularly and is available through prescription for individuals exhibiting hypogonadal symptoms, though seldom found on the black market.

Pregnyl for Pregnancy:

Pregnyl, or human chorionic gonadotropin, is a highly purified formulation sourced from the urine of pregnant women. When administered intramuscularly, it mimics the natural LH surge, triggering ovulation. Doctors recommend engaging in daily intercourse during the 48 hours following the LH surge to maximize chances of conception.

Your physician will provide guidance on optimal timing for intercourse or may suggest artificial insemination procedures in specific situations for enhanced pregnancy success.

HOW ARE HUMEGON AND PREGNYL ADMINISTERED?

Humegon is delivered via intramuscular injection, typically in the buttocks, as it cannot be ingested orally due to its protein composition.

Injections typically commence within the first five days of the menstrual cycle, potentially daily for 7 to 12 days. Dosages and schedules may alter based on individual response to treatment. Your physician may frequently adjust dosages or timing throughout cycles.

Pregnyl is administered intramuscularly based on your doctor’s assessment of necessary stimulation criteria. In certain cases of over-response, the injection may be postponed.

LENGTH OF TREATMENT

If conception does not occur, Humegon and Pregnyl may be administered again in the next cycle, though treatments may not always follow consecutively, as therapy is tailored to each patient.

Cycling may extend over six cycles, after which alternative options may be considered.

IS IT WORKING?

Successful ovulation triggers progesterone production from the ovaries, measurable via blood tests around one week post-ovulation.

In the absence of pregnancy, expect a menstrual period approximately 14 days post-HCG injection. Should your period not arrive, a blood test can confirm pregnancy status, followed by an ultrasound to monitor pregnancy progression.

CAREFUL MONITORING IS VITAL

Careful monitoring is essential for effective treatment and minimizing adverse reactions. This can involve two complementary methods: daily blood tests for estrogen levels and ultrasound imaging of the ovaries.

Higher estrogen levels indicate enhanced ovarian responsiveness to Humegon. Ultrasounds provide visual assessments of follicle number and size and help predict ovulation timing. Attending all scheduled tests and ultrasounds is crucial as results may necessitate treatment modifications.

SIDE EFFECTS/OTHER CONCERNS WITH TREATMENT

Humegon and Pregnyl may yield both minor and serious side effects; therefore, discuss potential risks with your physician prior to starting treatment.

Injection-site swelling, irritation, and pain may arise during Humegon therapy. Additional side effects may include headaches, abdominal discomfort, and mild to moderate ovarian enlargement. Report any concerning symptoms to your doctor for reassessment of treatment approaches. Similarly, Pregnyl injections can lead to injection site pain alongside headaches, irritability, restlessness, fatigue, and fluid retention.

Risks of multiple pregnancies are associated with medications like Humegon; approximately 80% of pregnancies result in single births, but twins are common, with rare incidences of triplets or more. Discuss multiple birth risks with your physician prior to commencing treatment.

It’s essential to address potential side effects and concerns with your doctor before initiating therapy.

HOW EFFECTIVE IS HUMEGON?

Humegon can promote ovulation in women with irregular cycles or anovulation, yet effectiveness varies based on infertility causes. Factors such as tubal condition, semen quality, and patient age also influence the likelihood of conception. If pregnancy does not occur during Humegon treatment, your physician will discuss alternative options.

CONCLUSION

Many healthy babies are now born through fertility treatments like Humegon and Pregnyl. Your doctor can address additional questions about these medications.